Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Lu

Showing results (881-890 of 897) with videos related to

Pageof 90
Sort By:
Eclinicalmedicine|January 16, 2026
Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09)Hong Yuan, Sheng Lu, De-Bin Sun, et al.
BMJ Open|November 27, 2019
Polymorphisms of genes related to vitamin D metabolism and transportation and its relationship with the risk of osteoporosis: protocol for a multicentre prospective cohort study in ChinaJing Wang, Bing Shu, Chen-Guang Li, et al.
Frontiers in Public Health|March 6, 2023
The prevalence of osteoporosis in China, a community based cohort study of osteoporosisJing Wang, Bing Shu, De-Zhi Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
Spin-Selective Oxygen Evolution in Chiral Molecule-Intercalated Layered Double HydroxidesChih-Ying Huang, Cheng-Rong Wu, Yang-Sheng Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2016
TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathwaysRun-Wei Yang, Ying-Yue Zeng, Wen-Ting Wei, et al.
Future Oncology (London, England)|January 18, 2023
A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trialSheng Lu, Yi-Gang Chen, Xiao-Wen Liu, et al.
Acta Cardiologica Sinica|January 24, 2022
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)Long-Sheng Lu, Yen-Wen Wu, Joseph Tung-Chieh Chang, et al.
Future Oncology (London, England)|October 8, 2024
Perioperative systemic and prophylactic intraperitoneal chemotherapy for type 4/large type 3 gastric cancer: DRAGON-10Zhi-Jian Jin, Sheng Lu, Min Shi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasisZhenggang Zhu, Joji Kitayama, Hyung-Ho Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2022
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinomaYuan-Hung Wu, Yi-Ping Hung, Nai-Chi Chiu, et al.
Pageof 90

Showing results (881-890 of 897) with videos related to

Sort By:
Pageof 90
Eclinicalmedicine|January 16, 2026
Intraperitoneal and intravenous paclitaxel plus S-1 and sintilimab as first-line treatment for gastric cancer with peritoneal metastasis: a single-arm phase 2 trial (DRAGON-09)Hong Yuan, Sheng Lu, De-Bin Sun, et al.
BMJ Open|November 27, 2019
Polymorphisms of genes related to vitamin D metabolism and transportation and its relationship with the risk of osteoporosis: protocol for a multicentre prospective cohort study in ChinaJing Wang, Bing Shu, Chen-Guang Li, et al.
Frontiers in Public Health|March 6, 2023
The prevalence of osteoporosis in China, a community based cohort study of osteoporosisJing Wang, Bing Shu, De-Zhi Tang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2026
Spin-Selective Oxygen Evolution in Chiral Molecule-Intercalated Layered Double HydroxidesChih-Ying Huang, Cheng-Rong Wu, Yang-Sheng Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2016
TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathwaysRun-Wei Yang, Ying-Yue Zeng, Wen-Ting Wei, et al.
Future Oncology (London, England)|January 18, 2023
A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trialSheng Lu, Yi-Gang Chen, Xiao-Wen Liu, et al.
Acta Cardiologica Sinica|January 24, 2022
Risk Management for Radiation-Induced Cardiovascular Disease (RICVD): The 2022 Consensus Statement of the Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) and Taiwan Society of Cardiology (TSOC)Long-Sheng Lu, Yen-Wen Wu, Joseph Tung-Chieh Chang, et al.
Future Oncology (London, England)|October 8, 2024
Perioperative systemic and prophylactic intraperitoneal chemotherapy for type 4/large type 3 gastric cancer: DRAGON-10Zhi-Jian Jin, Sheng Lu, Min Shi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasisZhenggang Zhu, Joji Kitayama, Hyung-Ho Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2022
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinomaYuan-Hung Wu, Yi-Ping Hung, Nai-Chi Chiu, et al.
Pageof 90